PMC:7195088 / 53669-53967
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1563 | 41-49 | Species | denotes | patients | Tax:9606 |
| 1571 | 32-40 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1572 | 228-239 | Disease | denotes | coinfection | MESH:D060085 |
| 1573 | 289-297 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T286 | 32-40 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T287 | 289-297 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T28167 | 121-132 | Chemical | denotes | antibiotics | http://purl.obolibrary.org/obo/CHEBI_33281 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T405 | 0-298 | Sentence | denotes | It is of note that up to 98% of COVID-19 patients in available experiences received intravenous broad-spectrum empirical antibiotics [28,44,45,47], probably reflecting the frequent inability to exclude the presence of bacterial coinfection at the onset of severe clinical presentations of COVID-19. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32360444-32007143-22369782 | 134-136 | 32007143 | denotes | 28 |
| 32360444-31986264-22369783 | 137-139 | 31986264 | denotes | 44 |
| 32360444-32109013-22369784 | 140-142 | 32109013 | denotes | 45 |